👀 Ones to watch: The MOST undervalued shares to buy right nowSee Undervalued Shares

Salesforce Macro Constraints are Evident - JPMorgan

Published 23/08/2022, 18:36
© Reuters
CRM
-

By Sam Boughedda

JPMorgan released a report on its Salesforce (NYSE:CRM) Partner Survey on Tuesday, telling investors that macro constraints are evident, but underlying resilience is still tangible.

An analyst who has an Overweight rating on Salesforce, outlined four key takeaways from the survey, which were that partners finished 2% above plan on average, a downtick from last quarter's +3.8%, most growth metrics experienced a downtick as expected, 85% of partners see lengthening sales cycles or greater deal scrutiny, and that there are a couple of measures to improve.

"Looking across the metrics, we see a sequential downtick in Perf-vs- Plan, Pace of Business, Bookings Expectations, MuleSoft/Tableau/Slack momentum, and tone of spending across Enterprise / Mid / Small Business segments. We still expect to see downticks accumulating due to the combination of inflation & rates, Fed tapering, stimulus withdrawal, recession talk, and the Russia-Ukraine war affecting business confidence. That said, the magnitude of deterioration appears manageable for now, and less severe than at the onset of the pandemic, though potentially softening in the coming quarters," said the analyst.

"Despite macro constraints, partners' expected CY22 practice growth rates actually up-ticked a point from 16% to 17%, while the expected runway for Salesforce to grow 15-20%+ also recovered from an uncharacteristic drop last quarter to a normal-looking level of 3.8 years," he added.

On lengthening sales cycles, the analyst said a large majority of partners are sensing pockets of elongation, with comments such as "our pipeline has widened, but close rate has slowed significantly" and "...people tucking in and holding tight to see what happens."

"One partner sees 'projects that were almost immediate are now 6 to 18 months from initial contact to actual contract signing', this behavior seems more pronounced in certain verticals such as Financial Services and offset by strength in Healthcare," said the analyst.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.